STARPHARMA HLDG.SP.ADR/10 (PQ6A) — Net Asset Quality Index
STARPHARMA HLDG.SP.ADR/10 (PQ6A) has a Net Asset Quality Index of 74.7% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €25.42 Million minus total liabilities of €6.42 Million yields net assets of €19.00 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read PQ6A liabilities breakdown for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
STARPHARMA HLDG.SP.ADR/10 Net Asset Quality Index Over Time (2022–2025)
This chart shows how STARPHARMA HLDG.SP.ADR/10's Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of June 2025, the index stands at 74.7%, representing net assets of €19.00 Million against total assets of €25.42 Million EUR. For live market cap and overall valuation, see PQ6A market cap overview.
Annual Net Asset Quality Index for STARPHARMA HLDG.SP.ADR/10 (2022–2025)
The table below presents the year-by-year Net Asset Quality Index for STARPHARMA HLDG.SP.ADR/10 from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See STARPHARMA HLDG.SP.ADR/10 net assets for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 74.7% | €19.00 Million | €25.42 Million | €6.42 Million | ▼ -1.6 pp |
| 2024 | 76.4% | €28.12 Million | €36.81 Million | €8.70 Million | ▲ +9.5 pp |
| 2023 | 66.8% | €34.81 Million | €52.09 Million | €17.27 Million | ▼ -6.3 pp |
| 2022 | 73.1% | €48.39 Million | €66.17 Million | €17.78 Million | — |